MY157186A - Drug delivery system for administration of poorly water soluble pharmaceutically active substances - Google Patents

Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Info

Publication number
MY157186A
MY157186A MYPI2010002787A MYPI20102787A MY157186A MY 157186 A MY157186 A MY 157186A MY PI2010002787 A MYPI2010002787 A MY PI2010002787A MY PI20102787 A MYPI20102787 A MY PI20102787A MY 157186 A MY157186 A MY 157186A
Authority
MY
Malaysia
Prior art keywords
delivery system
drug delivery
administration
water soluble
pharmaceutically active
Prior art date
Application number
MYPI2010002787A
Other languages
English (en)
Inventor
Aleksov Julian
Lokot Igor
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY157186(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Publication of MY157186A publication Critical patent/MY157186A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI2010002787A 2007-12-19 2008-12-18 Drug delivery system for administration of poorly water soluble pharmaceutically active substances MY157186A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2007/001127 WO2009078754A1 (en) 2007-12-19 2007-12-19 Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Publications (1)

Publication Number Publication Date
MY157186A true MY157186A (en) 2016-05-13

Family

ID=40795732

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI2010002787A MY157186A (en) 2007-12-19 2008-12-18 Drug delivery system for administration of poorly water soluble pharmaceutically active substances
MYPI2010002786A MY157187A (en) 2007-12-19 2008-12-18 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance

Family Applications After (1)

Application Number Title Priority Date Filing Date
MYPI2010002786A MY157187A (en) 2007-12-19 2008-12-18 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance

Country Status (27)

Country Link
US (4) US8999382B2 (OSRAM)
EP (1) EP2231189B1 (OSRAM)
JP (1) JP5466172B2 (OSRAM)
KR (1) KR101572703B1 (OSRAM)
CN (1) CN101951956B (OSRAM)
AU (1) AU2008339099B2 (OSRAM)
BR (1) BRPI0821740B1 (OSRAM)
CA (1) CA2709266C (OSRAM)
CY (2) CY1119805T1 (OSRAM)
DK (1) DK2231189T3 (OSRAM)
EA (1) EA015247B1 (OSRAM)
ES (1) ES2650242T3 (OSRAM)
FR (1) FR19C1030I1 (OSRAM)
HR (1) HRP20171796T1 (OSRAM)
HU (1) HUE034684T2 (OSRAM)
LT (2) LT2231189T (OSRAM)
LU (1) LUC00117I2 (OSRAM)
MX (1) MX2010006914A (OSRAM)
MY (2) MY157186A (OSRAM)
NL (1) NL300987I9 (OSRAM)
NO (2) NO2231189T3 (OSRAM)
NZ (1) NZ586859A (OSRAM)
PL (1) PL2231189T3 (OSRAM)
PT (1) PT2231189T (OSRAM)
SI (1) SI2231189T1 (OSRAM)
WO (2) WO2009078754A1 (OSRAM)
ZA (1) ZA201004685B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
KR20120022984A (ko) * 2009-04-21 2012-03-12 셀렉타 바이오사이언시즈, 인크. Ｔｈ１ 편향 반응을 제공하는 면역나노치료법
NO2575876T3 (OSRAM) 2010-05-26 2018-05-05
EP2640190A4 (en) 2010-11-05 2016-05-11 Selecta Biosciences Inc MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
CN103908432B (zh) * 2013-01-02 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种伊沙匹隆白蛋白的冻干组合物及其制备方法
CN112321465B (zh) * 2019-07-18 2023-06-06 上海现代药物制剂工程研究中心有限公司 一种含苯基化合物、其中间体、制备方法及应用
CN112239418B (zh) * 2019-07-18 2023-07-07 上海现代药物制剂工程研究中心有限公司 视黄醇类化合物及其钠盐的制备方法
WO2021259472A1 (en) * 2020-06-24 2021-12-30 Oasmia Pharmaceutical Ab Micellar docetaxel for use in the treatment of cancer
CN115429886B (zh) * 2021-06-02 2025-10-31 复旦大学 一种药物纳米结晶制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
US6197809B1 (en) * 1998-12-23 2001-03-06 Ardenia Investments Ltd. Compounds for the treatment of cancer
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (sv) * 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
US20050191359A1 (en) * 2001-09-28 2005-09-01 Solubest Ltd. Water soluble nanoparticles and method for their production
US20050249786A1 (en) * 2001-09-28 2005-11-10 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
HK1080447B (zh) * 2002-07-23 2008-10-31 Ardenia Investments, Ltd. 视黄醇衍生物、它们在治疗癌症和增强其它细胞毒性剂功效中的应用
SE0202311D0 (sv) * 2002-07-23 2002-07-23 Ardenia Investments Ltd Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
US7259984B2 (en) * 2002-11-26 2007-08-21 Cornell Research Foundation, Inc. Multibit metal nanocrystal memories and fabrication
JP2006199590A (ja) 2003-09-04 2006-08-03 Nano Career Kk 水溶性の塩基性薬物内包ナノ粒子含有組成物
WO2005089106A2 (en) 2004-02-27 2005-09-29 Molecular Therapeutics, Inc. Degradable nanoparticles
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8945629B2 (en) * 2004-09-10 2015-02-03 University Of Wyoming Nanoparticles for cytoplasmic drug delivery to cancer cells
CN101291658B (zh) * 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Also Published As

Publication number Publication date
US8999382B2 (en) 2015-04-07
EP2231189A4 (en) 2013-10-09
US9993438B2 (en) 2018-06-12
WO2009078802A1 (en) 2009-06-25
BRPI0821740B1 (pt) 2021-05-18
AU2008339099A1 (en) 2009-06-25
EP2231189A1 (en) 2010-09-29
NL300987I2 (OSRAM) 2019-05-09
JP2011507838A (ja) 2011-03-10
NL300987I9 (nl) 2019-05-16
PL2231189T3 (pl) 2018-03-30
US20150164819A1 (en) 2015-06-18
USRE49742E1 (en) 2023-12-05
CN101951956B (zh) 2012-10-17
PT2231189T (pt) 2017-12-12
NZ586859A (en) 2012-06-29
CY1119805T1 (el) 2018-06-27
DK2231189T3 (en) 2017-12-11
NO2231189T3 (OSRAM) 2018-02-03
LT2231189T (lt) 2017-12-27
CY2019021I2 (el) 2019-11-27
CA2709266A1 (en) 2009-06-25
MY157187A (en) 2016-05-13
US20110014281A1 (en) 2011-01-20
USRE49741E1 (en) 2023-12-05
CN101951956A (zh) 2011-01-19
CY2019021I1 (el) 2019-11-27
NO2019023I1 (no) 2019-05-08
MX2010006914A (es) 2010-11-10
CA2709266C (en) 2017-09-26
KR20100094575A (ko) 2010-08-26
EP2231189B1 (en) 2017-09-06
ZA201004685B (en) 2011-03-30
FR19C1030I1 (fr) 2019-06-21
ES2650242T3 (es) 2018-01-17
EA015247B1 (ru) 2011-06-30
HUE034684T2 (en) 2018-02-28
HRP20171796T1 (hr) 2018-01-26
BRPI0821740A2 (pt) 2020-02-27
SI2231189T1 (en) 2018-03-30
WO2009078754A1 (en) 2009-06-25
KR101572703B1 (ko) 2015-11-27
AU2008339099B2 (en) 2015-08-13
LUC00117I2 (OSRAM) 2024-05-22
JP5466172B2 (ja) 2014-04-09
EA200802350A2 (ru) 2009-06-30
EA200802350A3 (ru) 2009-10-30
LTPA2019508I1 (lt) 2019-05-10

Similar Documents

Publication Publication Date Title
MY157186A (en) Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2007121913A3 (en) Pharmaceutical solution formulations for pressurised metered dose inhalers
WO2008105773A3 (en) System for targeted delivery of therapeutic agents
MX2010002409A (es) Composiciones y metodos para la distribucion de farmacos escasamente solubles.
WO2008103409A3 (en) Compositions of chloroquine coupled to antibodies and to other proteins with methods for their synthesis
MX2009012279A (es) Distribucion de micro y nanoparticulas con plaquetas.
MY172519A (en) Solid polymeric controlled release nanoparticle
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2004105782A3 (en) Drug delivery systems for tumor targeting ngr-molecules and uses thereof
WO2011084316A3 (en) Formulations and methods for controlling mdi particle size delivery
EP2231192A4 (en) DRUG DISPENSING SYSTEM FOR THE ADMINISTRATION OF A WATER-SOLUBLE, CATIONIC AND AMPHIPHILIC PHARMACEUTICAL ACTIVE SUBSTANCE
Pornpitchanarong et al. Curcumin-incorporated Thiolated Chitosan/alginate Nanocarriers: Physicochemical Properties and Release Mechanism.
WO2006060325A3 (en) Coated drug delivery formulations
WO2014075203A8 (es) Nanopartículas con polímero biodegradable y biocompatible plga cargadas con el fármaco de uso humano pentoxfilina
TW200509985A (en) Drug delivery system for sub-Tenon administration of fine particles
MY150820A (en) Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
EA200971113A1 (ru) Шипучие таблетки для ингаляционного применения
CA2585754C (en) Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
WO2007109698A3 (en) Novel formulations
Liu et al. Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
HK40107352A (zh) 用於局部递送治疗剂的药物递送系统以及其用途
HK40107352B (zh) 用於局部递送治疗剂的药物递送系统以及其用途
HK40110475A (zh) 用於局部递送治疗剂的药物递送系统以及其用途
Patil Versatile applications of heterocyclic compounds: special attention to nanomaterials in cancer therapy